Please sign in with your existing account details.
Register to access exclusive content, sign up to receive our updates and personalise your experience on brownejacobson.com.
Privacy statement - Terms and conditions
Forgotten your password?
You have exceeded the maximum number of login attempts for this email address and your account has been locked. An email has been sent to member of Browne Jacobson's web team and some one will be contacting you over the next two working days with details of how to change your password.
Are you sure you want to remove this item from you pinned content?
The Schools Adjudicator has published a decision which criticised the admission policy for a faith school which gave priority to families who volunteered for activities in the local church. The adjudicator stated that the arrangements were contrary to the School Admissions Code 2012 and discriminated against single parents who had less time to volunteer for such activities and were not a test of that person’s faith but rather their availability. The decision has received a mixed response from secular and religious groups.
The decision, whilst receiving a mixed response, does provide further clarity for faith schools on how to approach the issue of priority for admission for faith based reasons. The decision should encourage faith schools to reconsider their policies and adopt criteria which are truly based on adherence to the faith (through church attendance) rather than any other support a family may provide to the school or religious body. Such an approach would protect the ethos of the school whilst ensuring the admission policy was fair, reasonable and objective.
With the Prime Ministers announcement that he intends for Step 4 to begin on 19 July, this will also bring an end to the restrictions currently in place on education settings.
View blog
The issue of Female Genital Mutilation Protection Orders and the importance of education providers to act promptly.
Our top tips for supporting transgender and non-binary pupils.
On 4 June, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the use of the Pfizer/BioNTech Covid-19 vaccine for 12- to 15-year-olds.
Partner
Select which mailings you would like to receive from us.
Sign up